|
WO2021038590A1
|
|
Novel polymorph of ribociclib succinate
|
|
WO2020261160A1
|
|
Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
|
|
WO2020225827A1
|
|
Novel polymorphs of ribociclib succinate
|
|
WO2020213014A1
|
|
An improved process for the preparation of valbenazine and its salts
|
|
WO2020202183A1
|
|
The process for the preparation of upadacitinib and its intermediates
|
|
WO2020202182A1
|
|
Process for the preparation of abaloparatide
|
|
WO2020178847A1
|
|
Cocrystal of roxadustat and d-proline
|
|
WO2020161743A1
|
|
Process for the preparation of bedaquiline fumarate
|
|
WO2020152718A1
|
|
Polymorphic forms 5-[3-[(1s)-2,3-dihydro-1-[(2-hydroxyethyl) amino]-1h-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)benzonitrile
|
|
WO2020121326A1
|
|
Amorphous (rac)-tramadol.hcl-celecoxib (1:1)
|
|
WO2020095316A1
|
|
Meloxicam co-crystals
|
|
WO2020075199A1
|
|
Polymorphic forms of vadadustat
|
|
WO2020044364A1
|
|
Polymorphic forms of avatrombopag maleate
|
|
CA3110155A1
|
|
Tramadol hbr-celecoxib co-crystal
|
|
WO2019215753A2
|
|
Process for preparation of pure plecanatide
|
|
CA3098274A1
|
|
Polymorphic forms of bictegravir and its sodium salt
|
|
WO2019207596A1
|
|
Novel crystalline forms of rucaparib (s)-camsylate salt and rucaparib free base
|
|
WO2019175724A1
|
|
Process for the preparation of abametapir and its pharmaceutically acceptable salts
|
|
WO2019166958A1
|
|
Process for the preparation of sotagliflozin
|
|
WO2019166962A1
|
|
Deutetrabenazine polymorphs and methods for their preparation
|
